Clinical Trial Update: Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results for pemetrexed plus oxaliplatin in locally advanced head and neck cancer, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Eloxatin (oxaliplatin)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-03-12